To further elucidate the specific mechanism underlying MAT’s therapeutic effect on RA, this study demonstrated that MAT could significantly decrease the levels of pro-inflammatory cytokines, including IL-1β, TNF-α, IL-17A, and IL-6, in the serum of CIA rats. This evidence concerns the gene IL17A and rheumatoid arthritis.